Remove Benchmarking Remove Numbers Remove Pharmaceutical Remove Valuation
article thumbnail

Transcript: David Conrod ā€“ The Big Picture

CFO News Room

I left HSBC Group at the end of 1999, and some friends of mine that Iā€™d known a long time had came on ā€” came out of the fixed income side at a number of investment banks, generally, top II-rated (ph) mortgage research and more ā€” traders, fixed income salesman, and to raise third-party capital broker-dealers required. CONROD: Sure.

article thumbnail

Transcript: Richard Bernstein

Barry Ritholtz

Everybody wants to sell a company when they get a good valuation. So up 18 or 19 percent for the year, you see those spectacular numbers. Obviously, profits, very important to company valuation — BERNSTEIN: Absolutely. The other thing we do, Barry, is we group valuation as a sentiment indicator. BERNSTEIN: Correct.

article thumbnail

Transcript: Joel Tillinghast, Fidelity

Barry Ritholtz

He has absolutely crushed his benchmark over that period. He’s crushed the Russell 2000, whatever benchmark you want to talk about. And because my mother and grandmother were looking at these trying to figure out what was going on, I was curious about the sea of numbers. The s and p 500 has underperformed his fund by 3.7%